Risk of dilution of share value through exercise of stock acquisition rights
First written in FY2022. 6 of 7 entries say "Materialised", first in FY2024-Q1. Latest entry: FY2027-H1.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2027-H1MaterialisedAnnual report
「1 December 2025–31 May 2026 (Note) 13,200 3,565,200 2,343 456,141 2,343 416,141 (Note) The increase resulted from the exercise of stock acquisition rights.」
During the interim consolidated fiscal period, 13,200 shares were issued through the exercise of stock acquisition rights, bringing the total number of issued shares to 3,565,200. Actual dilution from the exercise of stock acquisition rights has continued to occur. - FY2025MaterialisedAnnual report
「As of the end of November 2025, the number of potential shares represented by stock acquisition rights was 179,400, equivalent to 5.1% of the total 3,552,000 issued shares.」
During the fiscal year, 24,400 shares were issued through the exercise of stock acquisition rights, and the number of potential shares decreased from 203,800, or 5.8%, to 179,400, or 5.1%. Actual dilution has continued to occur. - FY2025-H1MaterialisedAnnual report
「1 December 2024–31 May 2025 17,000 3,544,600 6,587 451,434 6,587 411,434 (Note) The increase resulted from the exercise of stock acquisition rights.」
During the interim consolidated fiscal period, 17,000 shares were issued through the exercise of stock acquisition rights, bringing the total number of issued shares to 3,544,600. Actual dilution has continued to occur. - FY2024MaterialisedAnnual report
「1 December 2023–30 November 2024 Increase from the exercise of stock acquisition rights: 68,600 shares As of the end of November 2024, the number of potential shares represented by stock acquisition rights was 203,800, equivalent to 5.8% of the total 3,527,600 issued shares.」
During the fiscal year, 68,600 shares were issued through the exercise of stock acquisition rights, and dilution continued to occur. Meanwhile, the number of potential shares decreased from 275,200, or 8.3%, to 203,800, or 5.8%. - FY2024-Q2MaterialisedAnnual report
「1 March 2024–31 May 2024 1,400 3,486,400 248 434,258 248 394,258 (Note) 1. The increase resulted from the exercise of stock acquisition rights. 2. From 1 June 2024 through 30 June 2024, the total number of issued shares increased by 5,800 shares, and capital stock and capital surplus each increased by 2,247 thousand yen, due to the exercise of stock acquisition rights.」
During the second quarter accounting period, the total number of issued shares increased by 1,400 shares through the exercise of stock acquisition rights, and increased by a further 5,800 shares as of the filing date. Dilution from the exercise of stock acquisition rights has continued to occur. - FY2024-Q1MaterialisedAnnual report
「1 December 2023–29 February 2024 (Note) 1. The increase resulted from the exercise of stock acquisition rights. 2. From 1 March 2024 through 31 March 2024, the total number of issued shares increased by 1,400 shares, and capital stock and capital surplus each increased by 248 thousand yen, due to the exercise of stock acquisition rights.」
The total number of issued shares increased by 26,000 during the quarter through the exercise of stock acquisition rights, and increased by a further 1,400 shares by the filing date. Actual dilution from the exercise of stock acquisition rights has occurred. - FY2022First statedAnnual report
「As of the date of this document, the number of potential shares represented by stock acquisition rights was 275,200, equivalent to 8.3% of the total 3,314,000 issued shares.」
The company disclosed the potential dilution of equity value from the exercise of stock acquisition rights as a risk.